HOME >> BIOLOGY >> NEWS
Novel gene therapy on the horizon, says Brenner Children's Hospital pediatrician

WINSTON-SALEM, N.C. Researchers at Brenner Children's Hospital are working on a novel gene therapy to help new moms and their babies who suffer from genetic defects, according to findings reported at the Society of Pediatric Research in Seattle today.

R. Mark Payne, M.D., a pediatric cardiologist and researcher at Brenner Children's Hospital, has discovered a new way to transmit proteins across cell membranes a finding that in the future might prevent or treat diseases like Sudden Infant Death Syndrome (SIDS) and Trifunctional Protein (TFP) deficiency in infants and their mothers.

"The treatment involves getting the right protein into the cells or mitochondria they need to function properly," Payne said. "Mitochondria produce most of the energy within cells and defects in their function are among the most common genetic defects in the United States and currently can not be prevented."

Some genetic defects occur when mitochondria lack a certain protein, which cause babies, and in some cases their mothers, to become sick and die, Payne said. Current gene therapy attempts have tried injecting the patient with a virus that corrects the defect. However, the effectiveness of this approach is very poor and the side effects aren't good patients may die from the treatments, according to Payne.

"Instead of injecting a virus into the cells, we want to take the needed protein and inject only that protein into the cells," Payne said. "This is highly efficient technology the needed proteins get absorbed and are positioned correctly within the mitochondria located in the cell, which is necessary to correct the defect."

Payne and his colleagues say this new technology could mean that mothers suffering from genetic abnormalities such as TFP may be able to receive injections until their due date preventing premature delivery and sometimes death for both the mother and infant.

TFP is one of many genetic defects that involve mitochondria
'"/>

Contact: Rae Beasley
rabeasle@wfubmc.edu
336-716-6878
Wake Forest University Baptist Medical Center
4-May-2003


Page: 1 2

Related biology news :

1. Novel IBD therapeutic approaches reported from Washington Univ., Barcelona, LSU at APS meeting
2. Novel therapeutic bortezomib moves to phase II trial in lung cancer patients
3. Novel approaches to current cellular therapies continue progress toward disease prevention
4. Novel therapies show promise against myeloid leukemia
5. Novel sensors help clear the air
6. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
7. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
8. Novel therapeutic target identified in fight against Rheumatoid Arthritis
9. Novel bacterium detoxifies chlorinated pollutants
10. Novel flu vaccine shows promise in mice
11. Novel method identifies hidden genes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... (PRWEB) , ... August 19, 2020 , ... ... the premier conference and expo uniting life science, data science, informatics and IT ... sessions. , “In this period of uncertainty and change, Bio-IT takes the leadership ...
(Date:8/12/2020)... ... August 11, 2020 , ... Both Roche, based in ... into license agreements with Housey Pharma’s HMI subsidiary to gain access to its ... annual Research and Development spending in excess of US $10 billion. , Scientists ...
(Date:8/7/2020)... ... August 06, 2020 , ... Alucio™, ... to announce that Eric Chen and Jessica Wong have joined the company’s leadership ... Strategy, respectively. , Eric Chen heads development efforts for Alucio’s flagship product, Beacon, ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... ... August 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands ... , Known as MediVet Biologics since its formation in 2016, the company is ... Animal Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... reliable, solid-state radar transmitter systems that can be configured to drive Klystrons, TWTs, ... controller that can drive one or two switches in a push-pull configuration; yielding ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
Breaking Biology Technology:
Cached News: